QVT Financial LP - Q1 2016 holdings

$1.63 Billion is the total value of QVT Financial LP's 84 reported holdings in Q1 2016. The portfolio turnover from Q4 2015 to Q1 2016 was 37.5% .

 Value Shares↓ Weighting
XBI BuySPDR SERIES TRUSTput$289,296,000
-26.3%
5,600,000
+0.1%
17.74%
-19.5%
 VERISIGN INCsdcv 3.250% 8/1$103,695,000
+0.7%
40,000,0000.0%6.36%
+10.0%
GS BuyGOLDMAN SACHS GROUP INC$79,174,000
+485.7%
504,356
+572.5%
4.86%
+539.7%
NewTAL ED GROUPnote 2.500% 5/1$46,707,00024,000,000
+100.0%
2.86%
SellINTEL CORPsdcv 12/1$40,958,000
-21.4%
31,920,000
-21.0%
2.51%
-14.1%
MRVL BuyMARVELL TECHNOLOGY GROUP LTDord$40,448,000
+99.5%
3,923,182
+70.7%
2.48%
+117.9%
QIHU NewQIHOO 360 TECHNOLOGY CO LTDads$40,121,000531,047
+100.0%
2.46%
INTC BuyINTEL CORP$39,473,000
+168.0%
1,220,176
+185.4%
2.42%
+192.7%
NewSHIP FINANCE INTERNATIONAL Lnote 3.250% 2/0$37,258,00038,000,000
+100.0%
2.28%
SellWESCO INTL INCdbcv 6.000% 9/1$36,151,000
-41.2%
18,750,000
-51.9%
2.22%
-35.7%
MMYT BuyMAKEMYTRIP LIMITED MAURITIUS$35,041,000
+38.3%
2,034,024
+31.3%
2.15%
+51.0%
SellCTRIP COM INTL LTDnote 1.250%10/1$32,278,000
-30.5%
25,000,000
-28.6%
1.98%
-24.1%
PFF NewISHARES TRput$32,005,000820,000
+100.0%
1.96%
 MICROCHIP TECHNOLOGY INCsdcv 2.125%12/1$31,435,000
+4.7%
15,764,0000.0%1.93%
+14.3%
BuyCLOVIS ONCOLOGY INCnote 2.500% 9/1$29,665,000
+34.1%
43,295,000
+69.8%
1.82%
+46.5%
NYT BuyNEW YORK TIMES COcl a$29,006,000
+2.9%
2,327,896
+10.8%
1.78%
+12.4%
NAT NewNORDIC AMERICAN TANKERS LIMIput$26,947,0001,912,500
+100.0%
1.65%
ATEX BuyPDVWIRELESS INC$26,802,000
+23.6%
876,699
+1.4%
1.64%
+35.0%
NRE BuyNORTHSTAR REALTY EUROPE CORP$26,689,000
+37.0%
2,300,786
+39.5%
1.64%
+49.6%
WFC BuyWELLS FARGO & CO NEW$24,864,000
+15.8%
514,153
+30.2%
1.52%
+26.6%
THC BuyTENET HEALTHCARE CORP$23,312,000
-0.0%
805,823
+4.7%
1.43%
+9.2%
EQC SellEQUITY COMWLTH$22,576,000
-35.6%
800,000
-36.8%
1.38%
-29.7%
YOKU  YOUKU TUDOU INCsponsored adr$22,143,000
+1.3%
805,4990.0%1.36%
+10.7%
KANG NewIKANG HEALTHCARE GROUP INCsponsored adr$21,111,000965,717
+100.0%
1.30%
BLK NewBLACKROCK INCput$20,434,00060,000
+100.0%
1.25%
XLRN BuyACCELERON PHARMA INC$18,537,000
-40.6%
702,410
+9.7%
1.14%
-35.1%
 VIPSHOP HLDGS LTDnote 1.500% 3/1$17,595,000
-5.3%
17,500,0000.0%1.08%
+3.5%
 DHT HOLDINGS INCdebt 4.500%10/0$16,414,000
-18.8%
17,000,0000.0%1.01%
-11.3%
AGEN BuyAGENUS INC$16,129,000
+32.5%
3,877,072
+44.6%
0.99%
+44.8%
NAT NewNORDIC AMERICAN TANKERS LIMI$15,937,0001,131,120
+100.0%
0.98%
IBB SellISHARES TRnasdq biotec etf$15,691,000
-48.1%
60,164
-32.7%
0.96%
-43.3%
CYTR  CYTRX CORP$14,905,000
+2.9%
5,850,3990.0%0.91%
+12.4%
RLGY SellREALOGY HLDGS CORP$14,444,000
-46.8%
400,000
-45.9%
0.89%
-41.9%
EPZM BuyEPIZYME INC$14,317,000
+50.1%
1,181,244
+98.4%
0.88%
+64.1%
JPM BuyJPMORGAN CHASE & CO$13,436,000
+60.4%
226,879
+78.8%
0.82%
+75.3%
NewQIMONDA FIN LLCnote 6.750% 3/2$12,872,00082,885,000
+100.0%
0.79%
MRTX BuyMIRATI THERAPEUTICS INC$11,955,000
+50.6%
558,625
+122.4%
0.73%
+64.3%
XLNX NewXILINX INC$11,234,000236,855
+100.0%
0.69%
Z BuyZILLOW GROUP INCcl c cap stk$11,034,000
+10.6%
465,000
+9.4%
0.68%
+20.9%
NVGS SellNAVIGATOR HOLDINGS LTD$10,510,000
-56.4%
650,769
-65.6%
0.64%
-52.3%
VNET  21VIANET GROUP INCsponsored adr$10,488,000
-5.5%
525,1890.0%0.64%
+3.2%
TSM SellTAIWAN SEMICONDUCTOR MFG LTDput$10,480,000
-48.8%
400,000
-55.6%
0.64%
-44.1%
ICPT BuyINTERCEPT PHARMACEUTICALS IN$10,283,000
+1519.4%
80,044
+1782.9%
0.63%
+1652.8%
WLRH  WL ROSS HLDG CORP$10,030,000
+0.7%
1,000,0000.0%0.62%
+10.0%
SCTY  SOLARCITY CORP$10,000,000
-51.8%
406,8160.0%0.61%
-47.4%
SCTY  SOLARCITY CORPput$9,979,000
-51.8%
406,0000.0%0.61%
-47.4%
ARWR BuyARROWHEAD RESH CORP$9,870,000
-17.8%
2,047,782
+4.9%
0.60%
-10.2%
ZG  ZILLOW GROUP INCcl a$8,942,000
-1.9%
350,0000.0%0.55%
+7.0%
BMRN BuyBIOMARIN PHARMACEUTICAL INC$8,767,000
+215.4%
106,289
+300.5%
0.54%
+244.9%
SRPT BuySAREPTA THERAPEUTICS INC$8,775,000
+83.7%
449,526
+263.0%
0.54%
+100.7%
W  WAYFAIR INCput$8,644,000
-9.2%
200,0000.0%0.53%
-0.9%
W  WAYFAIR INCcl a$8,644,000
-9.2%
200,0000.0%0.53%
-0.9%
BRFS  BRF SAsponsored adr$8,633,000
+2.9%
607,1120.0%0.53%
+12.3%
RY NewROYAL BK CDA MONTREAL QUEput$8,634,000150,000
+100.0%
0.53%
KKR NewKKR & CO L P DEL$8,287,000564,149
+100.0%
0.51%
LBIO BuyLION BIOTECHNOLOGIES INC$8,119,000
-26.6%
1,598,309
+11.5%
0.50%
-19.8%
FPRX SellFIVE PRIME THERAPEUTICS INC$6,915,000
-32.5%
170,199
-31.1%
0.42%
-26.3%
TNK  TEEKAY TANKERS LTDcl a$6,684,000
-46.7%
1,821,3890.0%0.41%
-41.8%
HALO BuyHALOZYME THERAPEUTICS INC$6,576,000
-22.0%
694,436
+42.8%
0.40%
-14.8%
ADAP BuyADAPTIMMUNE THERAPEUTICS PLCsponds adr$6,371,000
-20.6%
783,645
+17.7%
0.39%
-13.3%
AVXS NewAVEXIS INC$6,224,000242,756
+100.0%
0.38%
ZXAIY  CHINA ZENIX AUTO INTL LTDads$5,435,000
+49.4%
6,074,8050.0%0.33%
+63.2%
GLNG  GOLAR LNG LTD BERMUDA$5,396,000
+13.8%
300,2830.0%0.33%
+24.4%
XNCR  XENCOR INC$5,193,000
-8.2%
386,9250.0%0.32%0.0%
ALR NewALERE INC$5,083,000100,442
+100.0%
0.31%
BGNE NewBEIGENE LTDsponsored adr$4,983,000170,000
+100.0%
0.31%
 YY INCnote 2.250% 4/0$4,875,000
+0.0%
5,000,0000.0%0.30%
+9.1%
BLCM BuyBELLICUM PHARMACEUTICALS INC$4,749,000
-31.3%
507,939
+49.0%
0.29%
-25.0%
RGNX BuyREGENXBIO INC$4,527,000
-12.7%
424,368
+20.7%
0.28%
-4.5%
FCSC  FIBROCELL SCIENCE INC$4,400,000
-47.3%
1,913,6620.0%0.27%
-42.4%
MDGN  MEDGENICS INC$3,817,000
-26.9%
867,6080.0%0.23%
-20.1%
BuyARRAY BIOPHARMA INCnote 3.000% 6/0$3,685,000
+29.2%
4,600,000
+53.3%
0.23%
+41.2%
AKTX  AKARI THERAPEUTICS PLCsponsored adr$3,205,000
-12.0%
263,9210.0%0.20%
-3.4%
ASMB BuyASSEMBLY BIOSCIENCES INC$3,049,000
-15.7%
740,700
+38.4%
0.19%
-7.9%
DHT  DHT HOLDINGS INC$2,653,000
-28.8%
460,5220.0%0.16%
-22.0%
EJ SellE HOUSE CHINA HLDGS LTDadr$2,590,000
-49.2%
416,438
-48.6%
0.16%
-44.4%
BLUE  BLUEBIRD BIO INC$2,508,000
-33.8%
59,0020.0%0.15%
-27.7%
OCRX  OCERA THERAPEUTICS INC$2,447,000
-15.9%
932,0860.0%0.15%
-8.0%
TCON  TRACON PHARMACEUTICALS INC$2,306,000
-31.3%
363,2920.0%0.14%
-25.0%
PTN  PALATIN TECHNOLOGIES INC$1,883,000
-18.7%
4,982,1740.0%0.12%
-11.5%
Z  ZILLOW GROUP INCput$1,424,000
+1.1%
60,0000.0%0.09%
+10.1%
MTG NewMGIC INVT CORP WIS$1,342,000175,000
+100.0%
0.08%
OCN NewOCWEN FINL CORP$741,000300,000
+100.0%
0.04%
DNAI  PRONAI THERAPEUTICS INC$472,000
-55.2%
70,0000.0%0.03%
-50.8%
PTCT ExitPTC THERAPEUTICS INC$0-117,600
-100.0%
-0.21%
XLE ExitSELECT SECTOR SPDR TRsbi int-energy$0-75,000
-100.0%
-0.25%
FSLR ExitFIRST SOLAR INCput$0-100,000
-100.0%
-0.37%
BONA ExitBONA FILM GROUP LTDsponsored ads$0-639,211
-100.0%
-0.48%
ExitMICRON TECHNOLOGY INCnote 1.625% 2/1$0-9,000,000
-100.0%
-0.73%
BCRX ExitBIOCRYST PHARMACEUTICALS$0-1,358,097
-100.0%
-0.79%
CFG ExitCITIZENS FINL GROUP INC$0-775,000
-100.0%
-1.14%
ExitRADIAN GROUP INCnote 2.250% 3/0$0-16,405,000
-100.0%
-1.19%
CBRE ExitCBRE GROUP INCcl a$0-660,000
-100.0%
-1.28%
SNDK ExitSANDISK CORP$0-387,805
-100.0%
-1.66%
LL ExitLUMBER LIQUIDATORS HLDGS INCput$0-2,969,100
-100.0%
-2.89%
ExitNOVELLUS SYS INCnote 2.625% 5/1$0-29,193,000
-100.0%
-3.86%
SPY ExitSPDR S&P 500 ETF TRput$0-400,000
-100.0%
-4.58%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-05-16
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MAKEMYTRIP LIMITED MAURITIUS38Q3 20236.2%
NEW YORK TIMES CO34Q3 20232.6%
ACCELERON PHARMA INC32Q3 20212.8%
JPMORGAN CHASE & CO32Q3 20212.2%
SAREPTA THERAPEUTICS INC32Q3 20231.1%
BIOMARIN PHARMACEUTICAL INC32Q3 20230.5%
GOLDMAN SACHS GROUP INC30Q3 20235.4%
ACADIA PHARMACEUTICALS INC28Q3 20230.2%
WELLS FARGO CO NEW27Q4 20201.5%
NEXSTAR MEDIA GROUP INC26Q3 20233.4%

View QVT Financial LP's complete holdings history.

Latest significant ownerships (13-D/G)
QVT Financial LP Q1 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
MP Materials Corp. / DEMay 18, 20238,853,7125.0%
Grindrod Shipping Holdings Ltd.Sold outFebruary 14, 202200.0%
AEHR TEST SYSTEMSSold outFebruary 14, 202000.0%
Arbutus Biopharma CorpSold outJuly 12, 201900.0%
Axovant Gene Therapies Ltd.Sold outJuly 12, 201900.0%
Myovant Sciences Ltd.Sold outJuly 12, 201900.0%
Urovant Sciences Ltd.Sold outJuly 12, 201900.0%
Axovant Sciences Ltd.March 19, 2019105,952,38158.2%
Hunter Maritime Acquisition Corp.Sold outFebruary 14, 201900.0%
AGENUS INCFebruary 14, 20183,201,2633.2%

View QVT Financial LP's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-07
SC 13G/A2024-03-07
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
42023-10-02
1442023-09-28
13F-HR2023-08-14
SC 13D/A2023-05-18
13F-HR2023-05-15

View QVT Financial LP's complete filings history.

Compare quarters

Issues

The following issues were detected while analyzing the report:

  • The reported total value is incorrect (1630708000.0 != 1630707000.0)

Export QVT Financial LP's holdings